Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort.

Gorlin PTCH1 SUFU childhood cancer predisposition syndrome medulloblastoma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 09 08 2021
accepted: 04 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 11 12 2021
Statut: epublish

Résumé

Gorlin syndrome is a genetic condition associated with the occurrence of SHH activated medulloblastoma, basal cell carcinoma, macrocephaly and other congenital anomalies. It is caused by heterozygous pathogenic variants in

Identifiants

pubmed: 34888241
doi: 10.3389/fonc.2021.756025
pmc: PMC8649840
doi:

Types de publication

Journal Article

Langues

eng

Pagination

756025

Informations de copyright

Copyright © 2021 Kloth, Obrecht, Sturm, Pietsch, Warmuth-Metz, Bison, Mynarek and Rutkowski.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet Oncol. 2004 Apr;5(4):209-18
pubmed: 15050952
Mayo Clin Proc. 2019 Jun;94(6):1084-1098
pubmed: 31171119
Cancer Cell. 2014 Mar 17;25(3):393-405
pubmed: 24651015
Nature. 2017 Jul 19;547(7663):311-317
pubmed: 28726821
J Neurol Neurosurg Psychiatry. 1978 Nov;41(11):1005-12
pubmed: 213536
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Neuro Oncol. 2011 Jun;13(6):669-79
pubmed: 21636711
Hum Genome Var. 2019 Feb 22;6:10
pubmed: 30820324
Am J Med Genet A. 2010 Feb;152A(2):327-32
pubmed: 20082463
J Clin Oncol. 2020 Jun 20;38(18):2028-2040
pubmed: 32330099
Cancer Cell. 2017 Jun 12;31(6):737-754.e6
pubmed: 28609654
Pediatr Neurol. 2020 Mar;104:3-12
pubmed: 31948735
Neurol Clin. 2007 Nov;25(4):925-46, viii
pubmed: 17964021
J Clin Neurosci. 2012 Nov;19(11):1541-4
pubmed: 22981874
Annu Rev Med. 2001;52:371-400
pubmed: 11160785
Nat Rev Cancer. 2008 Oct;8(10):743-54
pubmed: 18813320
Curr Oncol Rep. 2019 Aug 15;21(10):85
pubmed: 31414239
Nature. 2020 Apr;580(7803):396-401
pubmed: 32296180
Lancet Oncol. 2018 Jun;19(6):768-784
pubmed: 29778738
Cancer Metastasis Rev. 2020 Mar;39(1):211-233
pubmed: 31970590
Acta Neuropathol. 2014 Jul;128(1):137-49
pubmed: 24791927
N Engl J Med. 2015 Dec 10;373(24):2336-2346
pubmed: 26580448
JAMA Oncol. 2016 May 1;2(5):616-624
pubmed: 26822237
Neuro Oncol. 2009 Apr;11(2):201-10
pubmed: 18818397
Clin Neuropathol. 2016 Nov/Dec;35(6):344-352
pubmed: 27781424
Acta Derm Venereol. 2021 Apr 22;101(4):adv00434
pubmed: 33846763
J Clin Oncol. 2020 Jan 20;38(3):223-231
pubmed: 31774708
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Acta Neuropathol. 2011 Mar;121(3):381-96
pubmed: 21267586
J Clin Oncol. 2014 Dec 20;32(36):4155-61
pubmed: 25403219
Clin Cancer Res. 2009 Apr 1;15(7):2463-71
pubmed: 19276247
Am J Hum Genet. 2016 Jun 2;98(6):1256-1265
pubmed: 27236920
N Engl J Med. 2005 Mar 10;352(10):978-86
pubmed: 15758008
J Neurosurg. 1994 Nov;81(5):690-8
pubmed: 7931615
Am J Med Genet A. 2012 Feb;158A(2):391-9
pubmed: 22190277
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Fam Cancer. 2013 Dec;12(4):611-4
pubmed: 23479190
Lancet Oncol. 2018 Jun;19(6):785-798
pubmed: 29753700
Pediatr Blood Cancer. 2016 Sep;63(9):1527-34
pubmed: 27145464
Nat Rev Clin Oncol. 2011 Jun 28;8(9):540-9
pubmed: 21709698
N Engl J Med. 1960 May 5;262:908-12
pubmed: 13851319
Am J Med Genet A. 2017 Apr;173(4):1017-1037
pubmed: 28168833
Pediatr Blood Cancer. 2013 Aug;60(8):1247-52
pubmed: 23625733
Br J Dermatol. 2013 Dec;169(6):1342-5
pubmed: 23746055
Neuro Oncol. 2013 Jan;15(1):97-103
pubmed: 23099653
Neuro Oncol. 2020 Dec 18;22(12):1862-1872
pubmed: 32304218
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Fam Cancer. 2021 Oct;20(4):317-325
pubmed: 33860896
J Clin Oncol. 2020 Jan 1;38(1):43-50
pubmed: 31609649
Pediatr Neurosurg. 2003 Jul;39(2):60-7
pubmed: 12845195
Nat Med. 1998 May;4(5):619-22
pubmed: 9585239
Am J Hum Genet. 1967 Jan;19(1):12-22
pubmed: 4960000
Neuro Oncol. 2018 Jul 5;20(8):1122-1132
pubmed: 29186568
Nat Genet. 2002 Jul;31(3):306-10
pubmed: 12068298
J Clin Oncol. 2005 Jan 10;23(2):276-92
pubmed: 15637391
Clin Cancer Res. 2017 Jun 15;23(12):e62-e67
pubmed: 28620006
Front Oncol. 2020 Oct 29;10:566822
pubmed: 33194646
J Med Genet. 2007 Jul;44(7):424-8
pubmed: 17307835

Auteurs

Katja Kloth (K)

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Denise Obrecht (D)

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Dominik Sturm (D)

Hopp Children's Cancer Center (KiTZ) Heidelberg, Heidelberg, Germany.
Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany.
Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany.

Torsten Pietsch (T)

Department of Neuropathology, Deutsche Gesellschaft für Neuropathologie und Neuroanatomie (DGNN) Brain Tumor Reference Center, Bonn, Germany.

Monika Warmuth-Metz (M)

Institute of Diagnostic and Interventional Neuroradiology, University Hospital Wuerzburg, Wuerzburg, Germany.

Brigitte Bison (B)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, Augsburg, Germany.

Martin Mynarek (M)

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Stefan Rutkowski (S)

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Classifications MeSH